Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut du Cancer de Montpellier - Val d'Aurelle
Identification and evaluation of biomarkers of resistance to neoadjuvant chemotherapy and establishment of preclinical models of resistance in locally advanced breast cancer
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
proven invasive breast adenocarcinoma (cytology and / or biopsy).
* locally advanced stage (tumor size greater than 2 cm).
* Being affiliated to a social security scheme or an equivalent scheme of social protection
* Obtaining signed informed consent, and that before any specific prequalification testing.
You may not be if
presence of metastatic disease at diagnosis.
* Breast Cancer inflammatory.
* rare histologic subtypes (non ductal lobular and not).
* Other cancer (except basal cell skin carcinoma and cancer of the cervix in situ adequately treated and curative) treated in the previous 5 years.
* Patient pregnant or nursing or of childbearing age without effective contraception.
* Breast cancer in men.
* legal incapacity or limited legal capacity. medical or psychological conditions allowing the subject to complete the study or to sign the consent (art. L.1121-6, L.1121-7, L.1211-8, L1211-9).